Literature DB >> 16844272

Declining population immunity to mumps among Israeli military recruits.

Michael Huerta1, Nadav Davidovitch, Yair Aboudy, Omer E Ankol, Ran D Balicer, Salman Zarka, Itamar Grotto.   

Abstract

Population-based seroepidemologic data on mumps have not been available in Israel since 1987, and the effects of mass immigration from the Commonwealth of Independent States during the 1990s have not been investigated. We conducted a seroprevalence study of mumps antibodies among 353 Israeli military recruits aged 18-19, based on a representative sample of sera collected in 1999. The overall seroprevalence rate was 83.3%, which was significantly lower than that measured in 1987 (94.1%, P<0.001). Foreign-born subjects had substantially lower seroporevalence rates than their native Israeli counterparts (68.5% versus 86.1%, P<0.001). Recent seroprevalence levels are below those required for herd immunity, and most likely contributed to an outbreak of mumps observed among young adults in Israel in 2005. Immigration appears to be a contributing factor to the decrease in population seroprevalence over time.

Mesh:

Substances:

Year:  2006        PMID: 16844272     DOI: 10.1016/j.vaccine.2006.05.072

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease.

Authors:  Kh Muhsen; Y Aboudy; E Mendelson; M S Green; D Cohen
Journal:  Epidemiol Infect       Date:  2007-07-03       Impact factor: 2.451

2.  Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts.

Authors:  K Vainio; H H Samdal; G Anestad; E Wedege; D H Skutlaberg; K T Bransdal; R Mundal; I S Aaberge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-22       Impact factor: 3.267

3.  Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy.

Authors:  Jan Smetana; Roman Chlibek; Irena Hanovcova; Renata Sosovickova; Libuse Smetanova; Petra Polcarova; Peter Gal; Petr Dite
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

Review 4.  Personalized vaccines: the emerging field of vaccinomics.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Expert Opin Biol Ther       Date:  2008-11       Impact factor: 4.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.